SCHEMBL907519

SCHEMBL907519

C=CC(=O)NN1CCN(NC(=O)C=C)CC1

nearest known ligand 0.40

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.40
ALDH1A1 P00352 3/20 0.40
MAPK1 P28482 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
CA12 O43570 1/20 0.37
CA2 P00918 1/20 0.37
CA9 Q16790 1/20 0.37
TGM2 P21980 11/20 0.36
F13A1 P00488 7/20 0.36
TGM1 P22735 7/20 0.36
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
LMNA P02545 2/20 0.32
FGFR4 P22455 1/20 0.30
TGM3 Q08188 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28988331 1.00
SCHEMBL27091885 0.93 TSHR (0.38) TSHRALDH1A1MAPK1TDP1CA12
SCHEMBL26690315 0.90
SCHEMBL1337362 0.90 TGM2 (0.42) TSHRALDH1A1MAPK1TDP1CA12
SCHEMBL2733784 0.89 CA12 (0.53) MAPK1CA12CA2CA9MEN1
SCHEMBL615220 0.88 HTT (0.41) TSHRALDH1A1MAPK1TDP1TGM2
SCHEMBL3753325 0.84 TGM2 (0.45) TSHRALDH1A1MAPK1TDP1CA12
SCHEMBL1147261 0.84 CA12 (0.45) ALDH1A1CA12CA2CA9MEN1
SCHEMBL9420528 0.84 TSHR (0.33) TSHRALDH1A1MAPK1TDP1TGM2
SCHEMBL4120737 0.84 TSHR (0.40) TSHRALDH1A1MAPK1TDP1TGM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4124331-A1 AESTHETIC DENTAL FILLING MATERIAL WITH HIGH CURING DEPTH Ivoclar Vivadent AG (LI) 2023-02-01 EP claimed
EP-2277496-B1 Dental material containing surface-modified fillers IVOCLAR VIVADENT AG (LI) 2016-03-30 EP claimed
US-11827864-B2 Wipe with a guanidinyl-containing polymer 3M INNOVATIVE PROPERTIES COMPANY (US) 2023-11-28 US disclosed
US-20230100885-A1 WIPE WITH A GUANIDINYL-CONTAINING POLYMER SOLVENTUM INTELLECTUAL PROPERTIES COMPANY 2023-03-30 US disclosed
US-11576845-B2 Methods of removing spores comprising alcohol, acrylate copolymer particles, and a cationic coated article 3M INNOVATIVE PROPERTIES COMPANY (US) 2023-02-14 US disclosed
US-20210032578-A1 WIPE WITH A GUANIDINYL-CONTAINING POLYMER SOLVENTUM INTELLECTUAL PROPERTIES COMPANY 2021-02-04 US disclosed
EP-3013146-B1 WIPE WITH A GUANIDINYL-CONTAINING POLYMER 3M INNOVATIVE PROPERTIES CO (US) 2020-11-25 EP disclosed
US-10844337-B2 Wipe with a guanidinyl-containing polymer 3M INNOVATIVE PROPERTIES COMPANY (US) 2020-11-24 US disclosed
EP-3565522-A1 METHODS OF REMOVING SPORES 3M Innovative Properties Company (US) 2019-11-13 EP disclosed
EP-3565411-A1 METHODS OF REMOVING SPORES 3M Innovative Properties Company (US) 2019-11-13 EP disclosed
US-20190336409-A1 METHODS OF REMOVING SPORES 3M INNOVATIVE PROPERTIES COMPANY (US) 2019-11-07 US disclosed
US-5756742-A Polymerizable compounds HENKEL CORPORATION (US) 1998-05-26 US disclosed
WO-1998009994-A1 ADHESIVES FOR FLEXIBLE LAMINATES HENKEL CORPORATION (US) 1998-03-12 WO disclosed
US-5719202-A Polymerizable N,N'-substituted piperazine acrylamide compounds HENKEL CORPORATION (US) 1998-02-17 US disclosed
WO-1997023562-A1 POLYMERIZABLE COMPOUNDS HENKEL CORPORATION (US) 1997-07-03 WO disclosed
EP-0723542-A4 POLYMERIZABLE COMPOUNDS HENKEL CORP (US) 1996-10-23 EP disclosed
US-5565567-A Polymerizable N,N'-substituted piperazine acrylamide compounds HENKEL CORPORATION. (US) 1996-10-15 US disclosed
US-5563214-A Aqueous compositions containing polymerizable surfactant compounds HENKEL CORPORATION (US) 1996-10-08 US disclosed
EP-0723542-A1 POLYMERIZABLE COMPOUNDS HENKEL CORPORATION (US) 1996-07-31 EP disclosed
WO-1994029296-A1 POLYMERIZABLE COMPOUNDS HENKEL CORPORATION (US) 1994-12-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10844337-B2 Wipe with a guanidinyl-containing polymer GNPDA1, GDA, PGLS TSHR 4391/4885ALDH1A1 4262/4885MAPK1 4076/4885
US-11576845-B2 Methods of removing spores comprising alcohol, acrylate copolymer particles, and a cationic coated article ACR, CUTA, PRKDC TSHR 2090/4885ALDH1A1 1340/4885MAPK1 2722/4885
US-20190336409-A1 METHODS OF REMOVING SPORES CUTA, ACR, PRF1 TSHR 1949/4885ALDH1A1 1251/4885MAPK1 3568/4885
US-20210032578-A1 WIPE WITH A GUANIDINYL-CONTAINING POLYMER GNPDA1, GDA, PGLS TSHR 4391/4885ALDH1A1 4262/4885MAPK1 4076/4885
US-11827864-B2 Wipe with a guanidinyl-containing polymer GNPDA1, GDA, PGLS TSHR 4391/4885ALDH1A1 4262/4885MAPK1 4076/4885
US-20230100885-A1 WIPE WITH A GUANIDINYL-CONTAINING POLYMER GNPDA1, GDA, PGLS TSHR 4391/4885ALDH1A1 4262/4885MAPK1 4076/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.